H31.1
Choroidal degeneration
Clinical Classification Guidelines
Excludes Type 2
- angioid streaks of macula (H35.33)
Medical Intelligence & Overview
Choroidal degeneration refers to a group of eye conditions where the choroid, a layer of blood vessels and connective tissue located between the retina and the sclera (white of the eye), gradually deteriorates. This degeneration can lead to vision problems and, if left unmanaged, may cause significant visual impairment. The condition is often associated with aging but can also be linked to other factors that impact eye health. Recognizing the signs early and understanding its causes can aid in timely diagnosis and management.
Causes & Symptoms
Clinical Causes: Aging: The most common factor leading to choroidal degeneration, especially in older adults. Genetic predispositions that may contribute to weakening of the choroid. Chronic inflammation or inflammatory eye diseases such as uveitis. Age-related macular degeneration (AMD), particularly the atrophic (dry) form. Environmental factors like prolonged exposure to ultraviolet light. Lifestyle factors, including smoking and poor nutrition. Secondary to other systemic diseases such as hypertension or arteriosclerosis which affect blood vessels. Certain genetic conditions that predispose individuals to degenerative eye diseases.
Key Symptoms: Gradual loss of central vision, impacting activities such as reading or recognizing faces. Blurriness or distortion in vision. Presence of dark or empty areas in the visual field (scotomas). Difficulty adapting to low light conditions. Possible color perception changes. No symptoms in early stages; many individuals may be unaware of the degeneration until vision loss occurs. In some cases, visual discomfort or sensitivity to light.
Diagnostic & Treatment
Diagnosis Path: visual acuity testing to assess clarity of vision, fundus examination to observe changes in the choroid and retina, optical coherence tomography (OCT) for detailed imaging of the eye layers, and fluorescein angiography to evaluate blood flow within the choroid and retina. Additional tests may include Amsler grid assessments to detect visual distortions and electrophysiological tests if needed. An accurate diagnosis is crucial to differentiate this condition from other retinal or choroidal diseases.
Treatment Protocols: Regular monitoring of eye health through periodic eye examinations. Anti-angiogenic therapies are not typically used unless neovascularization occurs. Management of underlying systemic conditions such as hypertension and diabetes to improve overall vascular health. Use of nutritional supplements like vitamins C and E, zinc, lutein, and omega-3 fatty acids, which may support retinal and choroidal health. Protection from excessive UV light through sunglasses and proper eye protection. Low vision aids and adaptive devices to assist with daily activities if vision deteriorates. Emerging therapies and research are exploring regenerative treatments and gene therapies, but these are not yet standard care options. Lifestyle modifications, including smoking cessation, balanced diet, and avoiding eye strain.
Clinical Advice & FAQs
Billing Guidance
Is H31.1 a billable ICD-10 code?
Yes, H31.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H31.1?
Clinical documentation must specify the nature of Choroidal degeneration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
